KCM
ONC

Keywise Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Keywise Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-97,700
Closed -$15M – 20
2018
Q2 		$15M Sell
97,700
-126,800
-56% -$22.6M 5.09% 6
2018
Q1 		$37.7M Buy
+224,500
New +$30.4M 11.63% 4

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Keywise Capital Management's ONC Position: Q3 2018 in Review

Keywise Capital Management sold out of BeOne Medicines Ltd (ONC) in Q3 2018, closing a stake of 97,700 shares — an estimated $15M sold.

Keywise Capital Management first reported a position in ONC in Q1 2018 and held it in 2 quarters. The position peaked at $37.7M in Q1 2018. 144 funds tracked by Wall St. Rank hold ONC as of Q3 2018.

  • Keywise Capital Management reported no remaining BeOne Medicines Ltd position as of Q3 2018 after selling out during the quarter.
  • Keywise Capital Management sold 97,700 BeOne Medicines Ltd shares in Q3 2018, an estimated $15M.
  • Keywise Capital Management first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 2 quarters.
  • Keywise Capital Management's BeOne Medicines Ltd position peaked at $37.7M in Q1 2018.
  • 144 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2018.

Based on Keywise Capital Management's 13F filing for Q3 2018, filed 18 Oct 2018.